Compounding Pharmacies Market Synopsis

Compounding Pharmacies Market Size is Valued at USD 13.81 Billion in 2023, and is Projected to Reach USD 20.57 Billion by 2032, Growing at a CAGR of 5.11% From 2024-2032.

The term compounding pharmacies market pertains to the industry which deals in effectiveness of pharmacies that prepared specific medicines by blending, combining or modifying active chemicals in a way that is required by individual clients. These pharmacies serve the patients who may need special concentrations, different packaging, forms or components that normal commercially prepared products have. The specific therapeutic ancillary service of compounding pharmacies is important in-patient care because it addresses specific patient needs especially those with allergies, certain diseases, or those who need a special way to receive medication.

• The major driving forces that are discussed in this report are increasing incidences of chronic diseases and the need for personalized medicine. Due to the changes in understanding hospital management, attending to the needs of the patients, there is some appreciation of the need to be in a position to see that every person has his or her specific health issue and thus deserves specific care. Since compounding pharmacies can produce solutions that are unique for the purpose it serves in satisfying the therapeutic goals of a provider, patients are provided with better solutions and hence higher satisfaction is achieved. Also, time factor has also been coming eye to eye with compounded medication since most of the population is aging with more than one chronic condition that requires compounded medication.
• Another drastic force is the technological innovations within compounding techniques as well as in equipment being used in different industries. Advanced technology in compounding pharmacy technology consists of an automated dispensing system information technology on the formulation and techniques advanced in compounding pharmacy technology ensure efficiency and precision of the drugs compounded. Such developments also help to Efficiency of operation is also coupled with higher quality and safer compounded medications. In addition, approval for the raw material and the sector by Organ of Drug Control and for the compounding sector from organizations such as the U.S. Food and Drug Administration (FDA) provide further growth of compounding pharmacies.

Compounding Pharmacies Market Trend Analysis

Increasing integration of digital health technologies

• Digital health technologies are emerging as an important and growing trend in the compounding pharmacies market. Telehealth services, however, have found their place in many compounding pharmacies with EHR as a way of better communication between pharmacists and other healthcare professionals who are involved in patients’ treatment. This trend means that to set, measure, and monitor the needed medications and regimens, compounding pharmacists can readily adapt to changes in the patient state or preference. Further, advancement in the internet Pharmacy has made the compounded medications more easily available to the patients making these services available to any patient in need.
• Sustainability is the other new trend that is coming up in the compounding pharmacies market. Most pharmacies, today, are aiming at embracing natural products and cutting down their waste materials. Such a change is not only good for the business environment as it respects the more sensitive nature of the Earth, but also for environmentally-sensitive customers. When the public becomes more aware of the environment, being environmentally friendly will open a niche market for compounding pharmacies among patients seeking environmentally conscious pharmacies.

Expansion into Emerging Markets

• The compounding pharmacies market represents certain growth prospects in the newly developing markets. With a developing healthcare system in the developing nations, there is the continuing need to develop tailored drugs for the specific diseases of these people. These markets can therefore be penetrated by compounding pharmacies to market solutions that meet the needs of their regions. The benefits of this expansion are wider revenues and perhaps expansion of compounded pharmacy business throughout the world.
• Specialty Compounding Although, there is no significant area that highlights compounding pharmacy as a center of innovation for specialty compounding areas exist with special focus on veterinary medicine for animals, pediatric as well as hormone replacement therapy. Since compounding involves preparation of medicine in specific formulations for specific areas of specialization, compounding pharmacies cane set themselves apart from an ordinary compounding pharmacy. As consumers continue to demand personalized medication compounded formulations, pharmacies will also need to invest in developing new formulations to adopt to the markets and thus improve their services.

Compounding Pharmacies Market Segment Analysis:

Compounding Pharmacies Market Segmented on the basis of Product Type, By Formulation Type, Application and End User.

By product Type, Oral Compounds segment is expected to dominate the market during the forecast period

• The compounding pharmacies market can be categorized based on the type of product into oral compounds, topical compounds, injectable compounds and several other compounds. Oral compounds are preparations intended for internal use, which may be developed to achieve certain quantitatively or qualitatively necessary doses or to eliminate certain allergens. Topical compounds are of palatable dosage formulations which are intended for administration on to skin or mucosal surfaces, used in diseases affecting the skin. Injectable compounds means medicines as are developed especially for injections, and it can be different doses or component in the preparation especially for some patient needs. Other compounds include other formulations that are not in the previous categories which include suppositories or patches for patients with specific needs and or specific therapy needs.

By Application, Pain Management segment held the largest share in 2024

• The market for compounding pharmacies is also categorized by application which include pain management, hormone replacement therapy, dermatology, pediatric care and veterinary. Pain management products can be off the shelf or customized pain management solutions to patients in need of relief for chronic or acute pain issues: and because they may contain several active ingredients, the compounds have to be well formulated for effectiveness. Hormone replacement therapy is aimed at developing personalised hormonal preparations for people who have hormonal disorders, such as menopausal or andropausal ones. In dermatology, compounding pharmacies formulate specialized topical medications for different skin disorder that lets them tailor particular medication for certain condition such as atopic dermatitis or psoriasis. Specialty compounding includes compounding for pediatric patients where medicines are compounded to fit dosage and formulation needs in children and veterinary where medicines meet specific requirements of animals that are sick, formulas made for pets.

Compounding Pharmacies Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America represents the largest market for compounding pharmacies primarily because of the sound health care structure and rising need for customized medicines. Specifically, the largest share in it is held by the United States due to the growing incidence of chronic diseases and the proportion of the aging population that requires individualized approaches to therapy. Furthermore, there are many compounding pharmacies in this region together with wide acceptance of compounded medications among health care providers.
• The other factor affecting the compounder market in North America is the regulatory environment of the market. Thanks to sound rules set by these overseers like the FDA, compounding pharmacies are required to maintain quality formulation of drugs. This regulatory support coupled with technological enlightenment in the related market in North America makes it a continent of reference for other countries to emulate in compounding pharmacies development with a view of ensuring not only innovation but also safer patient administration.

Active Key Players in the Compounding Pharmacies Market

• Nephron Pharmaceuticals (USA)
• Fagron (Netherlands)
• Turing Pharmaceuticals (USA)
• Dwayne's Pharmacy (USA)
• Apothecary Shop (USA)
• Triangle Compounding Pharmacy (USA)
• Custom Meds (USA)
• Village Compounding Pharmacy (USA)
• L.M. Pharmacy (USA)
• Pharmacists’ Specialty Network (USA), Other Active Players

   

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Compounding Pharmacies Market by Product Type
 4.1 Compounding Pharmacies Market Snapshot and Growth Engine
 4.2 Compounding Pharmacies Market Overview
 4.3 Oral Compounds
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Oral Compounds: Geographic Segmentation Analysis
 4.4 Topical Compounds
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Topical Compounds: Geographic Segmentation Analysis
 4.5 Injectable Compounds
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Injectable Compounds: Geographic Segmentation Analysis
 4.6 Other Compounds
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Other Compounds: Geographic Segmentation Analysis

Chapter 5: Compounding Pharmacies Market by Formulation Type
 5.1 Compounding Pharmacies Market Snapshot and Growth Engine
 5.2 Compounding Pharmacies Market Overview
 5.3 Sterile Compounding
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Sterile Compounding: Geographic Segmentation Analysis
 5.4 Non-Sterile Compounding
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Non-Sterile Compounding: Geographic Segmentation Analysis

Chapter 6: Compounding Pharmacies Market by Application
 6.1 Compounding Pharmacies Market Snapshot and Growth Engine
 6.2 Compounding Pharmacies Market Overview
 6.3 Pain Management
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Pain Management: Geographic Segmentation Analysis
 6.4 Hormone Replacement Therapy
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hormone Replacement Therapy: Geographic Segmentation Analysis
 6.5 Dermatology
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Dermatology: Geographic Segmentation Analysis
 6.6 Pediatric
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Pediatric: Geographic Segmentation Analysis
 6.7 Veterinary
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Veterinary: Geographic Segmentation Analysis

Chapter 7: Compounding Pharmacies Market by End-User
 7.1 Compounding Pharmacies Market Snapshot and Growth Engine
 7.2 Compounding Pharmacies Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Home Healthcare
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Home Healthcare: Geographic Segmentation Analysis
 7.5 Specialty Clinics
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Specialty Clinics: Geographic Segmentation Analysis
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Geographic Segmentation Analysis

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Benchmarking
  8.1.2 Compounding Pharmacies Market Share by Manufacturer (2023)
  8.1.3 Industry BCG Matrix
  8.1.4 Heat Map Analysis
  8.1.5 Mergers and Acquisitions
  
 8.2 NEPHRON PHARMACEUTICALS (USA)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Role of the Company in the Market
  8.2.5 Sustainability and Social Responsibility
  8.2.6 Operating Business Segments
  8.2.7 Product Portfolio
  8.2.8 Business Performance
  8.2.9 Key Strategic Moves and Recent Developments
  8.2.10 SWOT Analysis
 8.3 FAGRON (NETHERLANDS)
 8.4 TURING PHARMACEUTICALS (USA)
 8.5 DWAYNE'S PHARMACY (USA)
 8.6 APOTHECARY SHOP (USA)
 8.7 TRIANGLE COMPOUNDING PHARMACY (USA)
 8.8 CUSTOM MEDS (USA)
 8.9 VILLAGE COMPOUNDING PHARMACY (USA)
 8.10 L.M PHARMACY (USA)
 8.11 PHARMACISTS SPECIALTY NETWORK (USA)
 8.12 OTHER ACTIVE PLAYERS

Chapter 9: Global Compounding Pharmacies Market By Region
 9.1 Overview
 9.2. North America Compounding Pharmacies Market
  9.2.1 Key Market Trends, Growth Factors and Opportunities
  9.2.2 Top Key Companies
  9.2.3 Historic and Forecasted Market Size by Segments
  9.2.4 Historic and Forecasted Market Size By Product Type
  9.2.4.1 Oral Compounds
  9.2.4.2 Topical Compounds
  9.2.4.3 Injectable Compounds
  9.2.4.4 Other Compounds
  9.2.5 Historic and Forecasted Market Size By Formulation Type
  9.2.5.1 Sterile Compounding
  9.2.5.2 Non-Sterile Compounding
  9.2.6 Historic and Forecasted Market Size By Application
  9.2.6.1 Pain Management
  9.2.6.2 Hormone Replacement Therapy
  9.2.6.3 Dermatology
  9.2.6.4 Pediatric
  9.2.6.5 Veterinary
  9.2.7 Historic and Forecasted Market Size By End-User
  9.2.7.1 Hospitals
  9.2.7.2 Home Healthcare
  9.2.7.3 Specialty Clinics
  9.2.7.4 Others
  9.2.8 Historic and Forecast Market Size by Country
  9.2.8.1 US
  9.2.8.2 Canada
  9.2.8.3 Mexico
 9.3. Eastern Europe Compounding Pharmacies Market
  9.3.1 Key Market Trends, Growth Factors and Opportunities
  9.3.2 Top Key Companies
  9.3.3 Historic and Forecasted Market Size by Segments
  9.3.4 Historic and Forecasted Market Size By Product Type
  9.3.4.1 Oral Compounds
  9.3.4.2 Topical Compounds
  9.3.4.3 Injectable Compounds
  9.3.4.4 Other Compounds
  9.3.5 Historic and Forecasted Market Size By Formulation Type
  9.3.5.1 Sterile Compounding
  9.3.5.2 Non-Sterile Compounding
  9.3.6 Historic and Forecasted Market Size By Application
  9.3.6.1 Pain Management
  9.3.6.2 Hormone Replacement Therapy
  9.3.6.3 Dermatology
  9.3.6.4 Pediatric
  9.3.6.5 Veterinary
  9.3.7 Historic and Forecasted Market Size By End-User
  9.3.7.1 Hospitals
  9.3.7.2 Home Healthcare
  9.3.7.3 Specialty Clinics
  9.3.7.4 Others
  9.3.8 Historic and Forecast Market Size by Country
  9.3.8.1 Bulgaria
  9.3.8.2 The Czech Republic
  9.3.8.3 Hungary
  9.3.8.4 Poland
  9.3.8.5 Romania
  9.3.8.6 Rest of Eastern Europe
 9.4. Western Europe Compounding Pharmacies Market
  9.4.1 Key Market Trends, Growth Factors and Opportunities
  9.4.2 Top Key Companies
  9.4.3 Historic and Forecasted Market Size by Segments
  9.4.4 Historic and Forecasted Market Size By Product Type
  9.4.4.1 Oral Compounds
  9.4.4.2 Topical Compounds
  9.4.4.3 Injectable Compounds
  9.4.4.4 Other Compounds
  9.4.5 Historic and Forecasted Market Size By Formulation Type
  9.4.5.1 Sterile Compounding
  9.4.5.2 Non-Sterile Compounding
  9.4.6 Historic and Forecasted Market Size By Application
  9.4.6.1 Pain Management
  9.4.6.2 Hormone Replacement Therapy
  9.4.6.3 Dermatology
  9.4.6.4 Pediatric
  9.4.6.5 Veterinary
  9.4.7 Historic and Forecasted Market Size By End-User
  9.4.7.1 Hospitals
  9.4.7.2 Home Healthcare
  9.4.7.3 Specialty Clinics
  9.4.7.4 Others
  9.4.8 Historic and Forecast Market Size by Country
  9.4.8.1 Germany
  9.4.8.2 UK
  9.4.8.3 France
  9.4.8.4 Netherlands
  9.4.8.5 Italy
  9.4.8.6 Russia
  9.4.8.7 Spain
  9.4.8.8 Rest of Western Europe
 9.5. Asia Pacific Compounding Pharmacies Market
  9.5.1 Key Market Trends, Growth Factors and Opportunities
  9.5.2 Top Key Companies
  9.5.3 Historic and Forecasted Market Size by Segments
  9.5.4 Historic and Forecasted Market Size By Product Type
  9.5.4.1 Oral Compounds
  9.5.4.2 Topical Compounds
  9.5.4.3 Injectable Compounds
  9.5.4.4 Other Compounds
  9.5.5 Historic and Forecasted Market Size By Formulation Type
  9.5.5.1 Sterile Compounding
  9.5.5.2 Non-Sterile Compounding
  9.5.6 Historic and Forecasted Market Size By Application
  9.5.6.1 Pain Management
  9.5.6.2 Hormone Replacement Therapy
  9.5.6.3 Dermatology
  9.5.6.4 Pediatric
  9.5.6.5 Veterinary
  9.5.7 Historic and Forecasted Market Size By End-User
  9.5.7.1 Hospitals
  9.5.7.2 Home Healthcare
  9.5.7.3 Specialty Clinics
  9.5.7.4 Others
  9.5.8 Historic and Forecast Market Size by Country
  9.5.8.1 China
  9.5.8.2 India
  9.5.8.3 Japan
  9.5.8.4 South Korea
  9.5.8.5 Malaysia
  9.5.8.6 Thailand
  9.5.8.7 Vietnam
  9.5.8.8 The Philippines
  9.5.8.9 Australia
  9.5.8.10 New Zealand
  9.5.8.11 Rest of APAC
 9.6. Middle East & Africa Compounding Pharmacies Market
  9.6.1 Key Market Trends, Growth Factors and Opportunities
  9.6.2 Top Key Companies
  9.6.3 Historic and Forecasted Market Size by Segments
  9.6.4 Historic and Forecasted Market Size By Product Type
  9.6.4.1 Oral Compounds
  9.6.4.2 Topical Compounds
  9.6.4.3 Injectable Compounds
  9.6.4.4 Other Compounds
  9.6.5 Historic and Forecasted Market Size By Formulation Type
  9.6.5.1 Sterile Compounding
  9.6.5.2 Non-Sterile Compounding
  9.6.6 Historic and Forecasted Market Size By Application
  9.6.6.1 Pain Management
  9.6.6.2 Hormone Replacement Therapy
  9.6.6.3 Dermatology
  9.6.6.4 Pediatric
  9.6.6.5 Veterinary
  9.6.7 Historic and Forecasted Market Size By End-User
  9.6.7.1 Hospitals
  9.6.7.2 Home Healthcare
  9.6.7.3 Specialty Clinics
  9.6.7.4 Others
  9.6.8 Historic and Forecast Market Size by Country
  9.6.8.1 Turkey
  9.6.8.2 Bahrain
  9.6.8.3 Kuwait
  9.6.8.4 Saudi Arabia
  9.6.8.5 Qatar
  9.6.8.6 UAE
  9.6.8.7 Israel
  9.6.8.8 South Africa
 9.7. South America Compounding Pharmacies Market
  9.7.1 Key Market Trends, Growth Factors and Opportunities
  9.7.2 Top Key Companies
  9.7.3 Historic and Forecasted Market Size by Segments
  9.7.4 Historic and Forecasted Market Size By Product Type
  9.7.4.1 Oral Compounds
  9.7.4.2 Topical Compounds
  9.7.4.3 Injectable Compounds
  9.7.4.4 Other Compounds
  9.7.5 Historic and Forecasted Market Size By Formulation Type
  9.7.5.1 Sterile Compounding
  9.7.5.2 Non-Sterile Compounding
  9.7.6 Historic and Forecasted Market Size By Application
  9.7.6.1 Pain Management
  9.7.6.2 Hormone Replacement Therapy
  9.7.6.3 Dermatology
  9.7.6.4 Pediatric
  9.7.6.5 Veterinary
  9.7.7 Historic and Forecasted Market Size By End-User
  9.7.7.1 Hospitals
  9.7.7.2 Home Healthcare
  9.7.7.3 Specialty Clinics
  9.7.7.4 Others
  9.7.8 Historic and Forecast Market Size by Country
  9.7.8.1 Brazil
  9.7.8.2 Argentina
  9.7.8.3 Rest of SA

Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies

Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research